Phase 3 Trial Shows Benefit of Empagliflozin for Pediatric Type 2 … – Drug Topics
© 2022 MJH Life Sciences and Drug Topics. All rights reserved. © 2022 MJH Life Sciences™ and Drug Topics. All rights reserved.Eli Lilly and Company and Boehringer Ingelheim announced their…